PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-29.84%
Negative revenue growth while CVE stands at 13.08%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-38.48%
Negative gross profit growth while CVE is at 10.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-75.06%
Negative EBIT growth while CVE is at 51.52%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-75.06%
Negative operating income growth while CVE is at 51.52%. Joel Greenblatt would press for urgent turnaround measures.
-74.25%
Negative net income growth while CVE stands at 106.70%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-74.75%
Negative EPS growth while CVE is at 104.17%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-74.75%
Negative diluted EPS growth while CVE is at 104.17%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.30%
Share change of 0.30% while CVE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.30%
Diluted share count expanding well above CVE's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
-1.22%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
68.77%
OCF growth above 1.5x CVE's 1.45%. David Dodd would confirm a clear edge in underlying cash generation.
445.88%
Positive FCF growth while CVE is negative. John Neff would see a strong competitive edge in net cash generation.
4.54%
10Y revenue/share CAGR under 50% of CVE's 67.64%. Michael Burry would suspect a lasting competitive disadvantage.
-86.86%
Negative 5Y CAGR while CVE stands at 67.64%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-42.75%
Negative 3Y CAGR while CVE stands at 60.40%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
55.03%
Positive long-term OCF/share growth while CVE is negative. John Neff would see a structural advantage in sustained cash generation.
-68.93%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-29.63%
Negative 3Y OCF/share CAGR while CVE stands at 29.56%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
12.32%
Below 50% of CVE's 264.11%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-94.62%
Negative 5Y net income/share CAGR while CVE is 264.11%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-69.06%
Negative 3Y CAGR while CVE is 65.06%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-15.29%
Negative equity/share CAGR over 10 years while CVE stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-76.73%
Negative 5Y equity/share growth while CVE is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-68.89%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
717.34%
Dividend/share CAGR of 717.34% while CVE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-63.63%
Negative 5Y dividend/share CAGR while CVE stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-27.41%
Negative near-term dividend growth while CVE invests at 20.71%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-14.94%
Firm’s AR is declining while CVE shows 7.85%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
107.58%
Inventory growth well above CVE's 7.18%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.21%
Asset growth 1.25-1.5x CVE's 0.88%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
1.67%
75-90% of CVE's 2.02%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
0.50%
We have some new debt while CVE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
11.11%
SG&A declining or stable vs. CVE's 25.61%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.